Federated Health Data Networks Enable Cross-Border Medical Insights and AI Innovation

European healthcare institutions have long struggled to leverage valuable, large-scale health data due to regulatory, technical, and organizational barriers that silo patient data within individual organizations. This article explores how federated health data networks (FHDNs) and federated learning are being implemented in Europe to allow sensitive, decentralized medical data to be securely and collectively analyzed for research, clinical decision support, and precision medicine—without transferring data across borders. Real-world initiatives such as Personal Health Train and Vantage6 illustrate the technical, governance, and trust requirements for such networks and the orchestrator role, highlighting Microsoft’s active involvement in standardization, orchestration, and privacy-by-design solutions. The article details the architectures and value proposition for clinicians, hospitals, pharma, and researchers, including improved access to diverse medical datasets, compliance with privacy regulations, and acceleration of healthcare R&D. Challenges covered include GDPR compliance, technical heterogeneity, incentive alignment, and the need for ongoing collaboration across organizational, national, and industry boundaries. Ultimately, FHDNs are shown to reduce barriers for AI development and enable innovative data-driven healthcare applications at scale in Europe.